Endocrine Abstracts

Sex differences in the metabolic syndrome and the associated cardiovascular risk profile are attributed to sex-specific sex steroid profiles, but the effects of sex steroid treatment remain incompletely understood.We evaluated the impact of low doses of sex-steroids on cardiovascular risk parameters in 41 young (age range 19–46 years), healthy, nonobese (BMI <29), transsexual subjects. 30 male-to-female (M–F) transsexuals received transderm...